Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus

Journal of Immunology

Volumn 180, Issue 2, 2008, Pages 1276-1284

  Chang, Nan Hua ^a   McKenzie, Tamara ^a   Bonventi, Gabriel ^a   Landolt Marticorena, Carolina ^a   Fortin, Paul R ^a,b   Gladman, Dafna ^a,b   Urowitz, Murray ^a,b   Wither, Joan E ^a,b,c  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIGEN; ANTIMALARIAL AGENT; AZATHIOPRINE; B CELL ACTIVATING FACTOR; B7 ANTIGEN; CD23 ANTIGEN; CD86 ANTIGEN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; AUTOANTIGEN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BLOOD SAMPLING; CELL COMPARTMENTALIZATION; CELL EXPANSION; CELL MATURATION; CELL POPULATION; CELL SUBPOPULATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; BLOOD; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM;

ADOLESCENT; ADULT; ANTIGENS, CD80; ANTIGENS, CD86; AUTOANTIGENS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTE SUBSETS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE;

EID: 40449091122     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.2.1276     Document Type: Article

References (64)

1. Suzuki, N., and T. Sakane. 1989. Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus. J. Clin. Invest. 83: 937-944.
2. Ueda, Y., T. Sakane, and T. Tsunematsu. 1989. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus. J. Immunol. 143: 3988-3993.
3. Liossis, S. N., B. Kovacs, G. Denni, G. M. Kammer, and G. C. Tsokos. 1996. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J. Clin. Invest. 98: 2549-2557.
4. Enyedy, E. J., J. P. Mitchell, M. P. Nambiar, and G. C. Tsokos. 2001. Defective FcγRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus. Clin. Immunol. 101: 130-135.
5. Folzenlogen, D., M. F. Hofer, D. Y. Leung, J. H. Freed, and M. K. Newell. 1997. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin. Immunol. Immunopathol. 83: 199-204.
6. Bijl, M., G. Horst, P. C. Limburg, and C. G. Kallenberg. 2001. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 60: 523-526.
7. Bar-Or, A., E. M. Oliveira, D. E. Anderson, J. I. Kreiger, M. Duddy, K. C. O'Conner, and D. A. Hafler. 2001. Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J. Immunol. 167: 5669-5677.
8. Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum. 40: 1725.
9. Gladman, D. D., D. Ibanez, and M. B. Urowitz. 2002. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. 29: 288-291.
10. Odendahl, M., A. Jacobi, A. Hansen, E. Feist, F. Hiepe, G. R. Burmester, P. E. Lipsky, A. Radbruch, and T. Dorner. 2000. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 165: 5970-5979.
11. Arce, E., D. G. Jackson, M. A. Gill, L. B. Bennett, J. Banchereau, and V. Pascual. 2001. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J. Immunol. 167: 2361-2369.
12. Wehr, C., H. Eibel, M. Masilamani, H. Illges, M. Schlesier, H. H. Peter, and K. Warnatz. 2004. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 113: 161-171.
13. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188: 1679-1689.
14. Tangye, S. G., Y.-J. Liu, G. Aversa, J. H. Phillips, and J. E. deVries. 1998. Identification of human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188: 1691-1703.
15. Hutloff, A., K. Buchner, K. Reiter, H. J. Baelde, M. Odendahl, A. Jacobi, T. Dorner, and R. A. Kroczek. 2004. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 50: 3211-3220.
16. Bohnhorst, J. O., M. B. Bjorgan, J. E. Thoen, J. B. Natvig, and K. M. Thompson. 2001. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome. J. Immunol. 167: 3610-3618.
17. Pascual, V., Y.-J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, and J. D. Capra. 1994. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180: 329-339.
18. Sims, G. P., R. Ettinger, Y. Shirota, C. H. Yarboro, G. G. Illei, and P. E. Lipsky. 2005. Identification and characterization of circulating human transitional B cells. Blood 105: 4390-4398.
19. Wei, C., J. Anolik, A. Cappione, B. Zheng, A. Pugh-Bernard, J. Brooks, E.-H. Lee, E. C. B. Milner, and I. Sanz. 2007. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 178: 6624-6633.
20. Anolik, J. H., J. W. Friedberg, B. Zheng, J. Barnard, T. Owen, E. Cushing, J. Kelly, E. C. Milner, R. I. Fisher, and I. Sanz. 2007. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clin. Immunol. 122: 139-145.
21. Milner, E. C., J. Anolik, A. Cappione, and I. Sanz. 2005. Human innate B cells: a link between host defense and autoimmunity? Springer Semin. Immunopathol. 26: 433-452.
22. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Prichard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Rapjael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
23. Goodnow, C. C., J. Crosbie, H. Jorgensen, R. A. Brink, and A. Basten. 1989. Induction of tolerance in mature peripheral B lymphocytes. Nature 342: 385-391.
24. H4-34 B cells in the maintenance of human B cell tolerance. J. Clin. Invest. 108: 1061-1070.
25. Cappione III, A., J. H. Anolik, A. Pugh-Bernard, J. Barnard, P. Dutcher, G. Silverman, and I. Sanz. 2005. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest. 115: 3205-3216.
26. Kim, T., Y. Kanayama, N. Negoro, M. Okamura, T. Takeda, and T. Inoue. 1987. Serum levels of interferons in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 70: 562-569.
27. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294: 1540-1543.
28. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197: 711-723.
29. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615.
30. Crow, M. K., K. A. Kirou, and J. Wohlgemuth. 2003. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36: 481-490.
31. Morikawa, K., H. Kubagawa, T. Suzuki, and M. D. Cooper. 1987. Recombinant interferon-α, -β, and -γ enhance the proliferative response of human B cells. J. Immunol. 139: 761-766.
32. Braun, D., I. Caramalho, and J. Demengeot. 2002. IFN-αβ enhances BCR-dependent B cell responses. Int. Immunol. 14: 411-419.
33. Jego, G., A. K. Palucka, J.-P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225-234.
34. Cheema, G. S., V. Roschke, D. M. Hilbert, and W. Stohl. 2001. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44: 1313-1319.
35. Zhang, J., V. Roschek, K. P. Baker, Z. Wang, G. S. Alarcon, B. J. Fessler, H. Bastian, R. P. Kimberly, and T. Zhou. 2001. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166: 6-10.
36. Stohl, W., S. Metyas, S. M. Tan, G. S. Cheema, B. Oamar, D. Xu, V. Roschke, Y. Wu, K. P. Baker, and D. M. Hilbert. 2003. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 48: 3475-3486.
37. Thien, M., T. G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20: 785-798.
38. Collins, C. E., A. L. Gavin, T. S. Migone, D. M. Hilbert, D. Nemazee, and W. Stohl. 2006. B lymphocyte stimulator (BlyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BlyS mRNA levels than with plasma BlyS protein levels. Arthritis Res. Ther. 8: R6.
39. Merrell, K. T., R. J. Benschop, S. B. Gauld, K. Aviszus, D. Decote-Ricardo, L. J. Wysocki, and J. C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity 25: 953-962.
40. Cooke, M. P., A. W. Heath, K. M. Shokat, Y. Zeng, F. D. Finkelman, P. S. Linsley, M. Howard, and C. C. Goodnow. 1994. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179: 425-438.
41. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3: 549-560.
42. O'Keefe, T. L., G. T. Williams, F. D. Batista, and M. S. Neuberger. 1999. Deficiency in CD22, a B cell-specific inhibitory receptor is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 8: 1307-1313.
43. Majeti, R., Z. Xu, T. G. Parslow, J. L. Olson, D. I. Daikh, N. Killeen, and A. Weiss. 2000. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103: 1059-1070.
44. Cornall, R. J., J. G. Cyster, M. L. Hibbs, A. R. Dunn, K. L. Otipoby, E. A. Clark, and C. C. Goodnow. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8: 497-508.
45. Tedder, T. F., M. Inaoki, and S. Sato. 1997. The CD19/21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6: 107-118.
46. Inaoki, M., S. Sato, B. C. Weintraub, C. C. Goodnow, and T. F. Tedder. 1997. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp. Med. 11: 1923-1931.
47. Liossis, S. N., E. E. Solomou, M. A. Dimopoulos, P. Panayiotidis, M. M. Mavrikakis, and P. P. Sfikakis. 2001. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J. Invest. Med. 49: 157-165.
48. Flores-Borja, F., P. S. Kabouridis, E. C. Jury, D. A. Isenberg, and R. A. Mageed. 2005. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 52: 3955-3965.
49. Grammer, A. C., R. Slota, R. Fisher, H. Gur, H. Girschick, C. Yarboro, G. G. Illei, and P. E. Lipsky. 2003. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Invest. 112: 1506-1520.
50. Odendahl, M., R. Keitzer, U. Wahn, F. Hiepe, A. Radbruch, T. Dorner, and R. Bunikowski. 2003. Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus. Ann. Rheum. Dis. 62: 851-858.
51. Bourne, T., M. Zukowska-Cooper, M. R. Salaman, M. H. Seifert, and D. A. Isenberg. 1998. Spontaneous immunoglobulin-producing capacity of cultures from lupus patients and normal donors following depletion of cells expressing CD19 or CD38. Clin. Exp. Immunol. 111: 611-616.
52. Harada, Y., M. M. Kawano, N. Huang, M. S. Mahmoud, I. A. Lisukow, K. Mihara, T. Tsujimoto, and A. Kuramoto. 1996. Identification of early plasma cells in peripheral blood and their clinical significance. Br. J. Haematol. 92: 184-191.
53. Cheung, Y. H., N. H. Chang, Y. C. Cai, G. Bonventi, R. Macleod, and J. E. Wither. 2005. Functional interplay between intrinsic B and T cell defects leads to amplification of autoimmune disease in New Zealand black chromosome 1 congenic mice. J. Immunol. 175: 8154-8164.
54. Viglianti, G. A., C. M. Lau, T. M. Hanley, B. A. Miko, M. J. Schlomchik, and A. Marshak-Rothstein. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19: 837-847.
55. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202: 1171-1177.
56. Bernasconi, N. L., N. Onai, and A. Lanzavecchia. 2003. A role for Toll-like receptors in acquired immunity: upregulation of TLR9 by BCR triggering in naïve B cells and constitutive expression in memory B cells. Blood 101: 4500-4504.
57. - naive human B cells. Blood 109: 1611-1619.
58. Papadimitraki, E. D., C. Choulaki, E. Koutala, G. Bertsias, C. Tsatsanis, I. Gergianaki, A. Raptopoulou, H. D. Kritikos, C. Mamalaki, P. Sidiropoulos, and D. T. Boumpas. 2006. Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 54: 3601-3611.
59. Macfarlane, D. E., and I. Manzel. 1998. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160: 1122-1131.
60. Cyster, J. G., and C. C. Goodnow. 1995. Protein tyrosine phosphatase 1C negative regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2: 12-24.
61. Inaoki, M., S. Sato, B. C. Weintraub, C. C. Goodnow, and T. F. Tedder. 1997. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp. Med. 186: 1923-1931.
62. Yurasov, S., H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M. C. Nussenzweig. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201: 703-711.
63. Yurasov, S., T. Tiller, M. Tsuiji, K. Velinzon, V. Pascual, H. Wardemann, and M. C. Nussenzweig. 2006. Persistent expression of autoantibodies in SLE patients in remission. J. Exp. Med. 203: 2255-2261.
64. Cuss, A. K., D. T. Avery, J. L. Cannons, L. J. Yu, K. E. Nichols, P. J. Shaw, and S. G. Tangye. 2006. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J. Immunol. 176: 1506-1516.